Loss of heterozygosity of CDKN2A (p16INK4a) and RB1 tumor suppressor genes in testicular germ cell tumors

被引:5
作者
Vladusic, Tomislav [1 ]
Hrascan, Reno [1 ]
Pecina-Slaus, Nives [2 ]
Vrhovac, Ivana [1 ]
Gamulin, Marija [3 ]
Franekic, Jasna [1 ]
Kruslin, Bozo [4 ]
机构
[1] Univ Zagreb, Fac Food Technol & Biotechnol, Dept Biochem Engn, Zagreb 10000, Croatia
[2] Univ Zagreb, Dept Biol, Sch Med, Lab Neurooncol,Croatian Inst Brain Res, Zagreb 10000, Croatia
[3] Rebro Univ Hosp Ctr, Dept Oncol, Zagreb, Croatia
[4] Sisters Mercy Univ Hosp, Ljudevit Jurak Dept Pathol, Zagreb, Croatia
关键词
loss of heterozygosity; CDKN2A; RB1; seminomas; nonseminomas; MICROSATELLITE MARKERS; CANCER; PROTEIN; EXPRESSION; DIFFERENTIATION; INACTIVATION; DEREGULATION; PATHWAY;
D O I
10.2478/v10019-010-0035-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Testicular germ cell tumors (TGCTs) are the most frequent malignances in young adult men. The two main histological forms, seminomas and nonseminomas, differ biologically and clinically. pRB protein and its immediate upstream regulator p16INK4a are involved in the RB pathway which is deregulated in most TGCTs. The objective of this study was to evaluate the occurrence of loss of heterozygosity (LOH) of the CDKN2A (p16INK4a) and RB1 tumor suppressor genes in TGCTs. Materials and methods. Forty TGCTs (18 seminomas and 22 nonseminomas) were analyzed by polymerase chain reaction using the restriction fragment length polymorphism or the nucleotide repeat polymorphism method. Results. LOH of the CDKN2A was found in two (6%) out of 34 (85%) informative cases of our total TGCT sample. The observed changes were assigned to two (11%) nonseminomas out of 18 (82%) informative samples. Furthermore, LOH of the RB1 was detected in two (6%) out of 34 (85%) informative cases of our total TGCT sample. Once again, the observed changes were assigned to two (10.5%) nonseminomas out of 19 (86%) informative samples. Both LOHs of the CDKN2A were found in nonseminomas with a yolk sac tumor component, and both LOHs of the RB1 were found in nonseminomas with an embryonal carcinoma component. Conclusions. The higher incidence of observed LOH in nonseminomas may provide a clue to their invasive behavior.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 30 条
[1]  
Adams PD, 1999, MOL CELL BIOL, V19, P1068
[2]   The retinoblastoma protein pathway in cell cycle control and cancer [J].
Bartek, J ;
Bartkova, J ;
Lukas, J .
EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) :1-6
[3]   Deregulation of the G1/S-phase control in human testicular germ cell tumours [J].
Bartkova, J ;
Rajpert-de Meyts, E ;
Skakkebæk, NE ;
Lukas, J ;
Bartek, J .
APMIS, 2003, 111 (01) :252-266
[4]   Deregulation of the RB pathway in human testicular germ cell tumours [J].
Bartkova, J ;
Lukas, C ;
Sorensen, CS ;
Rajpert-De Meyts, E ;
Skakkebæk, NE ;
Lukas, J ;
Bartek, J .
JOURNAL OF PATHOLOGY, 2003, 200 (02) :149-156
[5]   Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours [J].
Bartkova, J ;
Falck, J ;
Rajpert-De Meyts, E ;
Skakkebæk, NE ;
Lukas, J ;
Bartek, J .
ONCOGENE, 2001, 20 (41) :5897-5902
[6]   A genome-wide study of allelic imbalance in human testicular germ cell tumors using microsatellite markers [J].
Bergthorsson, JT ;
Agnarsson, BA ;
Gudbjartsson, T ;
Magnusson, K ;
Thoroddsen, A ;
Palsson, B ;
Bjornsson, J ;
Stefansson, K ;
Gulcher, J ;
Einarsson, GV ;
Amundadottir, LT ;
Barkardottir, RB .
CANCER GENETICS AND CYTOGENETICS, 2006, 164 (01) :1-9
[7]  
Chaubert P, 1997, AM J PATHOL, V151, P859
[8]  
Eble J.N., 2004, World Health Organisation Classification of Tumors: Pathology and Genetics of the Urinary System and Male Genital Organs, P217
[9]   Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model [J].
Faulkner, SW ;
Leigh, DA ;
Oosterhuis, JW ;
Roelofs, H ;
Looijenga, LHJ ;
Friedlander, ML .
BRITISH JOURNAL OF CANCER, 2000, 83 (06) :729-736
[10]   Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation [J].
Fombonne, J ;
Devouassoux-Shisheboran, M ;
Bouvier, R ;
Droz, JP ;
Benahmed, M ;
Krantic, S .
CANCER DETECTION AND PREVENTION, 2004, 29 (01) :1-7